PHARMACEUTICAL EQUIVALENCE AND IN VITRO DISSOLUTION SIMILARITY STUDIES OF COMMERCIALLY AVAILABLE METOCLOPRAMIDE HYDROCHLORIDE TABLETS

The present study aimed to develop and characterize Metoclopramide Hydrochloride Mouth Dissolving Tablets (MDTs) to provide rapid drug release, quick onset of action, and improved patient compliance, particularly for paediatric, geriatric, and dysphagic patients. Mouth dissolving tablets were prepared by the direct compression method using croscarmellose sodium and sodium starch glycolate as super disintegrants at different concentrations. A total of eight formulations (F1–F8) were developed and evaluated. All formulations exhibited acceptable physical characteristics with friability values below 1%, indicating adequate mechanical strength. Among all formulations, F8, containing 40 mg of sodium starch glycolate, exhibited the best performance with 83.33% drug content, 23 seconds wetting time, 25 seconds disintegration time, and 98.75% cumulative drug release within 30 minutes. Drug release kinetic analysis revealed that the optimized formulation best fitted the Zero-order kinetic model (R² = 0.963), indicating a nearly constant drug release pattern. Accelerated stability studies conducted at 25°C/60% RH, 30°C/75% RH, and 40°C/75% RH for three months demonstrated no significant changes in the dissolution profile, with cumulative drug release remaining above 95%, confirming the stability of the optimized formulation. The study concludes that Metoclopramide Hydrochloride mouth dissolving tablets prepared by the direct compression method provide rapid disintegration, excellent drug release, satisfactory physicochemical properties, and good stability. The optimized formulation has the potential to improve patient compliance and therapeutic efficacy by providing a convenient and effective oral dosage form for the management of nausea, vomiting, and related gastrointestinal disorders. Keywords: Metoclopramide Hydrochloride, Direct compression method, FTIR Studies, In vitro drug release studies

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-26
DOI
https://doi.org/10.5281/zenodo.23659105
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PHARMACEUTICAL EQUIVALENCE AND IN VITRO DISSOLUTION SIMILARITY STUDIES OF COMMERCIALLY AVAILABLE METOCLOPRAMIDE HYDROCHLORIDE TABLETS

Md. Abdul Shafi Mrs. M. Shravani*
Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

PHARMACEUTICAL EQUIVALENCE AND IN VITRO DISSOLUTION SIMILARITY STUDIES OF COMMERCIALLY AVAILABLE METOCLOPRAMIDE HYDROCHLORIDE TABLETS

Md. Abdul Shafi Mrs. M. Shravani*
article en

Abstract

The present study aimed to develop and characterize Metoclopramide Hydrochloride Mouth Dissolving Tablets (MDTs) to provide rapid drug release, quick onset of action, and improved patient compliance, particularly for paediatric, geriatric, and dysphagic patients. Mouth dissolving tablets were prepared by the direct compression method using croscarmellose sodium and sodium starch glycolate as super disintegrants at different concentrations. A total of eight formulations (F1–F8) were developed and evaluated. All formulations exhibited acceptable physical characteristics with friability values below 1%, indicating adequate mechanical strength. Among all formulations, F8, containing 40 mg of sodium starch glycolate, exhibited the best performance with 83.33% drug content, 23 seconds wetting time, 25 seconds disintegration time, and 98.75% cumulative drug release within 30 minutes. Drug release kinetic analysis revealed that the optimized formulation best fitted the Zero-order kinetic model (R² = 0.963), indicating a nearly constant drug release pattern. Accelerated stability studies conducted at 25°C/60% RH, 30°C/75% RH, and 40°C/75% RH for three months demonstrated no significant changes in the dissolution profile, with cumulative drug release remaining above 95%, confirming the stability of the optimized formulation. The study concludes that Metoclopramide Hydrochloride mouth dissolving tablets prepared by the direct compression method provide rapid disintegration, excellent drug release, satisfactory physicochemical properties, and good stability. The optimized formulation has the potential to improve patient compliance and therapeutic efficacy by providing a convenient and effective oral dosage form for the management of nausea, vomiting, and related gastrointestinal disorders. Keywords: Metoclopramide Hydrochloride, Direct compression method, FTIR Studies, In vitro drug release studies

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 15%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon